Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

There will be no phase 3 in high risk pts.

I never imagined there was any sure thing in investing but our resident board Kreskin Jake2234 apparently feels there are sure things. First he said that EDP-235 will fail its phase 2 trial. Now he say even if it succeeds that won't be a phase 3 trial. Amazing! So why does he say the latter?

Due to the availability of molnupiravir and Paxlovid, it is unethical for a physician to give a placebo to a high risk patient. There is no regulatory framework for this.

Bbbwwaaa hhaaa, looks like the FDA didn't consult with Kreskin, uh Jake, as there are a series of drugs to combat Covid in phase 3 trials. Apparently, our modern day Kreskin Jake doesn't know that Paxlovid isn't readily available everywhere the world, or that clinical trials can be conducted outside the US.

Phase 3 trial.

https://ir.ateapharma.com/news-releases/news-release-details/atea-advance-global-phase-3-registrational-study-bemnifosbuvir


Phase 3 trial.

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00215-6/fulltext


Phase 3 trial.

https://www.fiercepharma.com/pharma/gilead-touts-veklury-resilience-against-mutated-coronavirus-plots-phase-3-new-covid-oral


Phase 3 trial.

https://www.shionogi.com/global/en/news/2022/09/20220928.html


Phase 3 trials.

https://pharmaceutical-journal.com/article/feature/everything-you-need-to-know-about-the-covid-19-therapy-trials


There is a regulatory framework.

https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap